People
Education, Admissions &
Professional Highlights
J.D., Harvard Law School
B.A., University of Wisconsin, Madison
California
Washington, D.C.
- AV Preeminent, peer review rated (Martindale Hubbell’s highest rating)
- Selected 2024 Top 50 Lawyers in America
- Lecturer, Hitotsubashi University Graduate School of Law, Business Law Department
- Speaker, Practicing Law Institute programs on M&A and corporate law
- Speaker, UCLA Anderson Forecast
Overview
Mr. Wilson is the founder of the firm and serves as primary outside counsel to a large number of emerging growth and mature companies, both public and private. Such representations often commence at the initial formation stage and continue through ultimate sale or merger.
Mr. Wilson has particular expertise in mergers and acquisitions, strategic alliance and joint venture transactions, equity and convertible debt financings, executive compensation arrangements, and licensing, development and commercialization arrangements. He has completed more than 500 M&A transactions.
Mr. Wilson counsels numerous technology, life science, healthcare, industrial and other innovative companies, large and small, in connection with all aspects of their corporate, corporate finance, licensing, governance and other transactional needs.
A significant aspect of Mr. Wilson’s practice involves cross-border transactions spanning multiple jurisdictions. He has particular experience representing Japanese companies in their strategic alliances, often involving complex structuring, technology licensing, product development and marketing arrangements.
Mr. Wilson is resident in Tokyo and licensed to practice law in Japan as a registered foreign lawyer (Gaikokuho-Jimu-Bengoshi). In addition to his corporate practice, Mr. Wilson is an instructor at Hitotsubashi University Graduate School of Law, Business Law Department, teaching courses on M&A and strategic alliances.
Mr. Wilson formerly was a partner at Morrison & Foerster LLP, where he was Co-Chair of the Technology Transactions Group (Los Angeles), and Shartsis Friese LLP, where he was Chair of the Corporate Department.
Representative Transactions
Represented Biocartis NV and it’s U.S. affiliate in its acquisition of Respiratory IFV-RSV Panel assets from Janssen Pharmaceutical NV.
Represented Sleep Train in its $80 million acquisition of Sleep Country and in its $425 million sale to Mattress Firm.
Represented Anchor Brewing Company and its controlling shareholder, Fritz Maytag, in the sale of the Company.
FINANCINGS